Wang Xiaohong, Wang Haibin, Matsumoto Hiromichi, Roy Shyamal K, Das Sanjoy K, Paria Bibhash C
Department of Pediatrics, Ralph L. Smith Research Center, University of Kansas Medical Center, Kansas City 66160-7338, USA.
Development. 2002 Sep;129(17):4125-34. doi: 10.1242/dev.129.17.4125.
Heparin binding EGF-like growth factor (HB-EGF), encoded by the Hegfl gene, is considered as an important mediator of embryo-uterine interactions during implantation in mice. However, it is unknown whether HB-EGF is important for implantation in species with different steroid hormonal requirements. In mice and rats, maternal ovarian estrogen and progesterone (P(4)) are essential to implantation. In contrast, blastocyst implantation can occur in hamsters in the presence of P(4) alone. To ascertain whether HB-EGF plays any role in implantation in hamsters, we examined the expression, regulation and signaling of HB-EGF in the hamster embryo and uterus during the periimplantation period. We demonstrate that both the blastocyst and uterus express HB-EGF during implantation. Hegfl is expressed solely in the uterine luminal epithelium surrounding the blastocyst prior to and during the initiation of implantation. Hypophysectomized P(4)-treated pregnant hamsters also showed a similar pattern of implantation-specific Hegfl expression. These results suggest that uterine Hegfl expression at the implantation site is driven by either signals emanating from the blastocyst or maternal P(4), but not by maternal estrogen. However, in ovariectomized hamsters, uterine induction of Hegfl requires the presence of estrogen and activation of its nuclear receptor (ER), but not P(4). This observation suggests an intriguing possibility that an estrogenic or unidentified signal from the blastocyst is the trigger for uterine HB-EGF expression. An auto-induction of Hegfl in the uterus by blastocyst-derived HB-EGF is also a possibility. We further observed that HB-EGF induces autophosphorylation of ErbB1 and ErbB4 in the uterus and blastocyst. Taken together, we propose that HB-EGF production and signaling by the blastocyst and uterus orchestrate the 'two-way' molecular signaling to initiate the process of implantation in hamsters.
由Hegfl基因编码的肝素结合表皮生长因子样生长因子(HB-EGF)被认为是小鼠着床期间胚胎与子宫相互作用的重要介质。然而,HB-EGF在具有不同类固醇激素需求的物种的着床过程中是否重要尚不清楚。在小鼠和大鼠中,母体卵巢雌激素和孕酮(P(4))对于着床至关重要。相比之下,仅在孕酮存在的情况下,仓鼠的胚泡就可以着床。为了确定HB-EGF在仓鼠着床过程中是否发挥作用,我们研究了围植入期仓鼠胚胎和子宫中HB-EGF的表达、调控及信号传导。我们证明,在着床期间,胚泡和子宫均表达HB-EGF。在着床开始前及着床期间,Hegfl仅在围绕胚泡的子宫腔上皮中表达。垂体切除并用P(4)处理的怀孕仓鼠也表现出类似的着床特异性Hegfl表达模式。这些结果表明,着床部位子宫Hegfl的表达是由胚泡发出的信号或母体P(4)驱动的,而不是由母体雌激素驱动的。然而,在卵巢切除的仓鼠中,子宫中Hegfl的诱导需要雌激素的存在及其核受体(ER)的激活,而不是P(4)。这一观察结果提示了一种有趣的可能性,即来自胚泡的雌激素信号或未知信号是子宫HB-EGF表达的触发因素。胚泡来源的HB-EGF对子宫中Hegfl的自诱导也是一种可能性。我们进一步观察到,HB-EGF可诱导子宫和胚泡中ErbB1和ErbB4的自磷酸化。综上所述,我们提出,胚泡和子宫产生的HB-EGF及其信号传导协调了“双向”分子信号传导,从而启动了仓鼠的着床过程。